版本:
中国

BRIEF-Nektar Therapeutics presents new preclinical data for its immuno-oncology programs

April 4 Nektar Therapeutics:

* Nektar Therapeutics says presents new preclinical data for its immuno-oncology programs at american association for cancer research (AACR) annual meeting Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐